Angiogenesis consists of an important feature of malignant tissues through which oxygen supply is maintained for a constantly growing tumour mass, whereas cancer cells can also escape their primary site and metastasize to distant normal tissues. The established role of antiangiogenic treatments in cancer, such as bevacizumab and sunitinib, delineates the significance of angiogenesis as a significant process to inhibit. Several efforts have been made to image in vivo tumour angiogenesis and its changes following treatment with anti-angiogenic factors; a humanized mouse monoclonal antibody against Vascular Endothelial Growth Factor (VEGF), HuMV833, was labeled with 124I and entered a phase I clinical trial, which demonstrated a fairly heterogeneous antibody distribution and clearance on PET imaging, in patients with advanced malignancies.
Journal of Physical Medicine & Rehabilitation Open Access is one of the top online publishing journals for research from the field of Angiogenesis. The open access articles published in this scholarly journal are reviewed by at least two reviewers of the associated fields. The journal publishes original research articles, reviews, case reports, short communications, etc and emphasizes theoretical and experimental work. To ensure high quality articles, both editors and reviewers actively participate in the peer review process and help in completing the review process within 21 days. As an important educational platform the journal provides scientists and researchers access to the newest trends and research outlooks. Please browse through the list of peer-reviewed journals to find the scientific publication of your interest.
Last date updated on September, 2014